HF
ALNY icon

HRT Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

HRT Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-128,633
Closed -$38.8M – 4101
2026
Q1 		$42.6M Buy
+128,633
New +$43.8M 0.11% 154
2025
Q4 		– Sell
-291,449
Closed -$133M – 3117
2025
Q3 		$133M Buy
291,449
+273,562
+1,529% +$111M 0.49% 22
2025
Q2 		$5.83M Sell
17,887
-37,286
-68% -$10.3M 0.03% 468
2025
Q1 		$14.9M Buy
55,173
+5,273
+11% +$1.36M 0.09% 160
2024
Q4 		$11.7M Buy
+49,900
New +$13.1M 0.06% 198
2024
Q2 		– Sell
-41,927
Closed -$6.26M – 2158
2024
Q1 		$6.26M Buy
+41,927
New +$6.99M 0.04% 215
2023
Q4 		– Sell
-2,090
Closed -$370K – 2265
2023
Q3 		$370K Buy
+2,090
New +$399K ﹤0.01% 1568
2022
Q2 		– Sell
-1,938
Closed -$316K – 2874
2022
Q1 		$316K Buy
+1,938
New +$295K ﹤0.01% 2196
2021
Q4 		– Sell
-30,777
Closed -$5.81M – 3112
2021
Q3 		$5.81M Buy
30,777
+24,261
+372% +$4.55M 0.04% 281
2021
Q2 		$1.1M Buy
6,516
+1,292
+25% +$189K 0.01% 963
2021
Q1 		$737K Buy
5,224
+3,389
+185% +$510K 0.01% 1493
2020
Q4 		$238K Sell
1,835
-20,589
-92% -$2.75M ﹤0.01% 1417
2020
Q3 		$3.26M Buy
+22,424
New +$3.19M 0.09% 145
2019
Q2 		– Sell
-7,576
Closed -$707K – 733
2019
Q1 		$707K Buy
+7,576
New +$634K 0.11% 134

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's ALNY Position: Q2 2026 in Review

HRT Financial sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 128,633 shares — an estimated $38.8M sold.

HRT Financial first reported a position in ALNY in Q1 2019 and held it in 14 quarters. The position peaked at $133M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • HRT Financial reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 128,633 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $38.8M.
  • HRT Financial first reported a position in Alnylam Pharmaceuticals in Q1 2019 and held it in 14 quarters.
  • HRT Financial's Alnylam Pharmaceuticals position peaked at $133M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.